xgeva®

Accord Healthcare Announces Launch of Denosumab – Second Biosimilar in Bone Health

∇ This medicine is subject to additional monitoring. This will allow quick identification of new safety information.LONDON, Dec. 2, 2025 /PRNewswire/…

3 weeks ago